Team
Deep Expertise in
Technology Commercialization
Team
Deep Expertise in
Technology Commercialization
Scaleup Partners is a company-building VC designing end-to-end growth for deep tech startups.
We provide hands-on partnership that drives tangible growth—from technology validation and commercialization to capital market access.
Taekyu Lee | CEO
Mr. Lee holds a B.S. in Electronic Engineering from Korea University and an M.S. in Pharmaceutical Industry Studies from Sungkyunkwan University. He has over 30 years of experience in technology commercialization and venture investment, having worked at Samsung Electronics’ Business Planning Team and Wonik Investment Partners. He oversees firm-wide investment strategy and the full investment lifecycle of technology-driven companies.
Mr. Ryu holds a B.A. in Statistics from Korea University and has extensive experience in bond and fund management at IBK Investment & Securities, Shinhan BNP Paribas Asset Management, and Korea Investment Management. He leads the firm’s exit strategy and capital markets execution.
Sik-yeol Ryu | PartnerMr. Ryu holds a B.A. in Statistics from Korea University and has extensive experience in bond and fund management at IBK Investment & Securities, Shinhan BNP Paribas Asset Management, and Korea Investment Management. He leads the firm’s exit strategy and capital markets execution.
Mr. Park holds a B.A. in Business Administration from Chung-Ang University. He previously managed finance at OCI and served as Head of Planning & Management at Wonik Investment Partners. He oversees compliance, risk management, and internal control systems at Scaleup Partners.
Gyeongseop Park | PartnerMr. Park holds a B.A. in Business Administration from Chung-Ang University. He previously managed finance at OCI and served as Head of Planning & Management at Wonik Investment Partners. He oversees compliance, risk management, and internal control systems at Scaleup Partners.
Dr. Park earned his B.S. and M.S. in Microbiology from Seoul National University and a Ph.D. in Medicine from the University of Ulsan. He has held research and clinical positions at Samsung Advanced Institute of Technology, Dong-A Pharmaceutical Research Institute, and Asan Medical Center. He is a biotechnology and healthcare expert specializing in drug R&D and commercialization strategy.
Seojin Park | Executive DirectorDr. Park earned his B.S. and M.S. in Microbiology from Seoul National University and a Ph.D. in Medicine from the University of Ulsan. He has held research and clinical positions at Samsung Advanced Institute of Technology, Dong-A Pharmaceutical Research Institute, and Asan Medical Center. He is a biotechnology and healthcare expert specializing in drug R&D and commercialization strategy.
Dr. Kang obtained his Ph.D. from the University of New South Wales under the supervision of Harvard Medical School Professor David Sinclair. Building on his career at Heungkuk Securities, Shinhan Capital, and Quad investment Management, he applies his scientific and financial expertise to provide strategic guidance that supports the growth of portfolio companies.
Myungjin Kang | DirectorDr. Kang obtained his Ph.D. from the University of New South Wales under the supervision of Harvard Medical School Professor David Sinclair. Building on his career at Heungkuk Securities, Shinhan Capital, and Quad investment Management, he applies his scientific and financial expertise to provide strategic guidance that supports the growth of portfolio companies.
Dr. Kim holds a Ph.D. in Nano Science and Technology from Sungkyunkwan University and manages portfolios in advanced materials, components, and AI. He focuses on bridging the gap between early-stage core technologies and market application by structuring investments and financing strategies.
Byeonghoon Kim | General ManagerDr. Kim holds a Ph.D. in Nano Science and Technology from Sungkyunkwan University and manages portfolios in advanced materials, components, and AI. He focuses on bridging the gap between early-stage core technologies and market application by structuring investments and financing strategies.
Ms. Baek holds a B.A. in Public Administration from Chung-Ang University. With prior internship experience at the Health Insurance Review & Assessment Service (HIRA), she is responsible for strategic planning and fund administration at Scaleup Partners.
Eunkyung Baek | ManagerMs. Baek holds a B.A. in Public Administration from Chung-Ang University. With prior internship experience at the Health Insurance Review & Assessment Service (HIRA), she is responsible for strategic planning and fund administration at Scaleup Partners.
Ms. Kim is an accelerator with extensive experience in startup support programs, including the Scale-up Startup Package at Gyeonggi Center for Creative Economy & Innovation. She is responsible for operating investment-linked acceleration and incubation programs.
Jihye Kim | ManagerMs. Kim is an accelerator with extensive experience in startup support programs, including the Scale-up Startup Package at Gyeonggi Center for Creative Economy & Innovation. She is responsible for operating investment-linked acceleration and incubation programs.
Ms. Yoo supports fund operations and provides comprehensive management support, contributing to the stability and operational efficiency of the funds.
Hyewon Yoo | Associate ManagerMs. Yoo supports fund operations and provides comprehensive management support, contributing to the stability and operational efficiency of the funds.
Mr. Auh earned a B.A. in Real Estate from New York University and is currently pursuing an M.S. in Pharmaceutical Industry Studies at Sungkyunkwan University. He previously completed an internship at Boston Consulting Group (BCG) and worked at Eugene Investment & Securities. At Scaleup Partners, he is responsible for research and exit strategy development.
Jungsoo Auh | AssosiateMr. Auh earned a B.A. in Real Estate from New York University and is currently pursuing an M.S. in Pharmaceutical Industry Studies at Sungkyunkwan University. He previously completed an internship at Boston Consulting Group (BCG) and worked at Eugene Investment & Securities. At Scaleup Partners, he is responsible for research and exit strategy development.
Mr. Ryu holds a B.A. in Statistics from Korea University and has extensive experience in bond and fund management at IBK Investment & Securities, Shinhan BNP Paribas Asset Management, and Korea Investment Management. He leads the firm’s exit strategy and capital markets execution.
Sik-yeol Ryu | PartnerMr. Ryu holds a B.A. in Statistics from Korea University and has extensive experience in bond and fund management at IBK Investment & Securities, Shinhan BNP Paribas Asset Management, and Korea Investment Management. He leads the firm’s exit strategy and capital markets execution.
Mr. Park holds a B.A. in Business Administration from Chung-Ang University. He previously managed finance at OCI and served as Head of Planning & Management at Wonik Investment Partners. He oversees compliance, risk management, and internal control systems at Scaleup Partners.
Gyeongseop Park | PartnerMr. Park holds a B.A. in Business Administration from Chung-Ang University. He previously managed finance at OCI and served as Head of Planning & Management at Wonik Investment Partners. He oversees compliance, risk management, and internal control systems at Scaleup Partners.
Dr. Park earned his B.S. and M.S. in Microbiology from Seoul National University and a Ph.D. in Medicine from the University of Ulsan. He has held research and clinical positions at Samsung Advanced Institute of Technology, Dong-A Pharmaceutical Research Institute, and Asan Medical Center. He is a biotechnology and healthcare expert specializing in drug R&D and commercialization strategy.
Seojin Park | Executive DirectorDr. Park earned his B.S. and M.S. in Microbiology from Seoul National University and a Ph.D. in Medicine from the University of Ulsan. He has held research and clinical positions at Samsung Advanced Institute of Technology, Dong-A Pharmaceutical Research Institute, and Asan Medical Center. He is a biotechnology and healthcare expert specializing in drug R&D and commercialization strategy.
Dr. Kang obtained his Ph.D. from the University of New South Wales under the supervision of Harvard Medical School Professor David Sinclair. Building on his career at Heungkuk Securities, Shinhan Capital, and Quad investment Management, he applies his scientific and financial expertise to provide strategic guidance that supports the growth of portfolio companies.
Myungjin Kang | DirectorDr. Kang obtained his Ph.D. from the University of New South Wales under the supervision of Harvard Medical School Professor David Sinclair. Building on his career at Heungkuk Securities, Shinhan Capital, and Quad investment Management, he applies his scientific and financial expertise to provide strategic guidance that supports the growth of portfolio companies.
Dr. Kim holds a Ph.D. in Nano Science and Technology from Sungkyunkwan University and manages portfolios in advanced materials, components, and AI. He focuses on bridging the gap between early-stage core technologies and market application by structuring investments and financing strategies.
Byeonghoon Kim | General ManagerDr. Kim holds a Ph.D. in Nano Science and Technology from Sungkyunkwan University and manages portfolios in advanced materials, components, and AI. He focuses on bridging the gap between early-stage core technologies and market application by structuring investments and financing strategies.
Ms. Baek holds a B.A. in Public Administration from Chung-Ang University. With prior internship experience at the Health Insurance Review & Assessment Service (HIRA), she is responsible for strategic planning and fund administration at Scaleup Partners.
Eunkyung Baek | ManagerMs. Baek holds a B.A. in Public Administration from Chung-Ang University. With prior internship experience at the Health Insurance Review & Assessment Service (HIRA), she is responsible for strategic planning and fund administration at Scaleup Partners.
Ms. Kim is an accelerator with extensive experience in startup support programs, including the Scale-up Startup Package at Gyeonggi Center for Creative Economy & Innovation. She is responsible for operating investment-linked acceleration and incubation programs.
Jihye Kim | ManagerMs. Kim is an accelerator with extensive experience in startup support programs, including the Scale-up Startup Package at Gyeonggi Center for Creative Economy & Innovation. She is responsible for operating investment-linked acceleration and incubation programs.
Ms. Yoo supports fund operations and provides comprehensive management support, contributing to the stability and operational efficiency of the funds.
Hyewon Yoo | Associate ManagerMs. Yoo supports fund operations and provides comprehensive management support, contributing to the stability and operational efficiency of the funds.
Mr. Auh earned a B.A. in Real Estate from New York University and is currently pursuing an M.S. in Pharmaceutical Industry Studies at Sungkyunkwan University. He previously completed an internship at Boston Consulting Group (BCG) and worked at Eugene Investment & Securities. At Scaleup Partners, he is responsible for research and exit strategy development.
Jungsoo Auh | AssosiateMr. Auh earned a B.A. in Real Estate from New York University and is currently pursuing an M.S. in Pharmaceutical Industry Studies at Sungkyunkwan University. He previously completed an internship at Boston Consulting Group (BCG) and worked at Eugene Investment & Securities. At Scaleup Partners, he is responsible for research and exit strategy development.